IP Library Granted Patent US 9,493,742
Granted Patent B2
US 9,493,742 · App. 14/211,430 · Granted Nov 15, 2016

Purification of cell mixtures using molecular beacons targeting cell specific RNA

Inventors: Young Sup Yoon (Atlanta, GA); Gang Bao (Mableton, GA); Kiwon Ban (Decatur, GA); Brian Wile (Grayson, GA)
Assignees: Emory University; Georgia Tech Research Corporation
C12N5/0657C12Q1/6881C12N2506/02C12N2506/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,493,742
App. No.
14/211,430
Granted
Nov 15, 2016
Kind
B2
Abstract

This disclosure is in the area of research and therapeutics. In certain embodiments, it provides methods to assist in the purification of cell mixtures, e.g., cardiomyocytes, using molecular beacons targeting cell-type specific RNA, e.g. mRNA.

Claims (8)

1. A method for purifying cardiomyocytes comprising,

a) introducing a molecular beacon comprising a loop sequence having SEQ ID NO: 4 into a mixture of cardiomyocytes and pluripotent stem cells under conditions such that the molecular beacon hybridizes to mRNA in the cardiomyocytes providing molecular beacon bound fluorescent cardiomyocytes; and

b) purifying the molecular beacon bound fluorescent cardiomyocytes by fluorescence activated cell sorting providing a purified composition of cardiomyoctyes.

2. The method of claim 1 , wherein the mixture of cardiomyocytes and pluripotent stem cells have been differentiated by a method comprising:

a) culturing undifferentiated pluripotent stem cells under conditions such that a monolayer of the undifferentiated stem cells is formed,

b) applying bone morphogenetic protein 4 (BMP4), Activin A, and fibroblast growth factor 2 (FGF2) to the undifferentiated stem cells under conditions such that cardiac linage cells are formed, and

c) treating the cardiac linage cells with isoproterenol to generate spontaneous beating cardiomyocytes.

3. The method of claim 1 , wherein pluripotent stem cells are mammalian pluripotent stem cells.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2015
From: BAO, GANG; WILE, BRIAN
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 034651/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2014
From: YOON, YOUNG-SUP; BAN, KIWON
To: EMORY UNIVERSITY
Reel/Frame 034023/0133 →
CONFIRMATORY LICENSE Recorded Sep 8, 2014
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033695/0677 →
Continuity (2)
Provisional Application 61787364 · Mar 15, 2013
Related Publication 20140335606A1 · Nov 13, 2014